JOSHUA ALDERMAN: Open Payments
NPI 1639622962 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 73 payments from 17 companies in 2025. Trend: 2023 $2,440 · 2024 $1,654 · 2025 $1,563
Food & beverage: $1,563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $427 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $238 |
| Ardelyx, Inc. | 7 | $169 |
| QOL Medical, LLC | 3 | $129 |
| Gilead Sciences, Inc. | 5 | $107 |
| Madrigal Pharmaceuticals | 3 | $97 |
| Janssen Biotech, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Intercept Pharmaceuticals, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: XIFAXAN, SKYRIZI, IBSRELA, Sucraid, REZDIFFRA, RINVOQ, TREMFYA, MAVYRET.
Industry payments across CT — which companies pay providers there.
